|
Beyond Trastuzumab
This new article (full-text via link) seems to provide the answers (the authors had read our minds. 
"Beyond Trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer."
http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
*******************
Today, 04:50 AM
I appreciate how helpful you are with research/info, Jackie. Thank you.
This is from the link you shared:
Summary of Key Conclusions
- HER2, estrogen receptor (ER)–positive patients with early-stage breast cancer at significantly increased risk of recurrent disease within 2.5 years after diagnosis
- Peak in annual recurrence rate at 2 years in HER2-positive group
- AIs reduce the risk of recurrence in HER2-positive patients
- Trastuzumab should be considered for ER-positive, HER2-positive patients given that inhibition of growth factor signaling may increase response to endocrine therapy
----------------
So what I get out of this is that Her2 pos, ER pos patients are given the hormone blockers because of their increased risk of reoccurence within the first 2 1/2 years after diagnosis. We know the benifits of Trastuzumab in this picture too.
I would assume that the majority of patients are utilizing every big gun we have to fight this and I am wondering what the research shows as to results as I don't have a clear picture of that.
Does anybody know the actual percentage of Her2 positive breast cancer patients that experience metastisis despite full treatment? I would appreciate knowing. Anybody here's oncologist discuss rate of metastisis and survival statistics for those fully treated with all the standards of care: surgery, chemo, radiation, herceptin, hormone blockers?
Thank you very much,
Paula
03-03-2012, 07:05 PM
Hopeful and Barbara2 have posted a couple of recent articles on this thread where Rich also provided some links:
http://her2support.org/vbulletin/sho...ce+rate&page=2
03-03-2012, 08:00 AM
Does anybody have current statistics on the reoccurence rate and percentage of those who end up with metastisis for those who are Her2 positive who have surgery, chemo, Herceptin, radiation, and hormone blockers? I would be interested in published research results as well as what people here are hearing from their own oncologists.
Thanks,
Paula
__________________
Jackie07
http://www.kevinmd.com/blog/2011/06/doctors-letter-patient-newly-diagnosed-cancer.html
http://www.asco.org/ASCOv2/MultiMedi...=114&trackID=2
NICU 4.4 LB
Erythema Nodosum 85
Life-long Central Neurocytoma 4x5x6.5 cm 23 hrs 62090 semi-coma 10 d PT OT ST 30 d
3 Infertility tmts 99 > 3 u. fibroids > Pills
CN 3 GKRS 52301
IDC 1.2 cm Her2 +++ ER 5% R. Lmptmy SLNB+1 71703 6 FEC 33 R Tamoxifen
Recc IIB 2.5 cm Bi-L Mast 61407 2/9 nds PET
6 TCH Cellulitis - Lymphedema - compression sleeve & glove
H w x 4 MUGA 51 D, J 49 M
Diastasis recti
Tamoxifen B. scan
Irrtbl bowel 1'09
Colonoscopy 313
BRCA1 V1247I
hptc hemangioma
Vertigo
GI - > yogurt
hysterectomy/oophorectomy 011410
Exemestane 25 mg tab 102912 ~ 101016 stopped due to r. hip/l.thigh pain after long walk
DEXA 1/13
1-2016 lesions in liver largest 9mm & 1.3 cm onco. says not cancer.
3-11 Appendectomy - visually O.K., a lot of puss. Final path result - not cancer.
Start Vitamin D3 and Calcium supplement （600mg x2)
10-10 Stopped Exemestane due to r. hip/l.thigh pain OKed by Onco 11-08-2016
7-23-2018 9 mm groundglass nodule within the right lower lobe with indolent behavior. Due to possible adenocarcinoma, Recommend annual surveilence.
7-10-2019 CT to check lung nodule.
1-10-2020 8mm stable nodule on R Lung, two 6mm new ones on L Lung, a possible lymph node involvement in inter fissule.
"I WANT TO BE AN OUTRAGEOUS OLD WOMAN WHO NEVER GETS CALLED AN OLD LADY. I WANT TO GET SHARP EDGED & EARTH COLORED, TILL I FADE AWAY FROM PURE JOY." Irene from Tampa
Advocacy is a passion .. not a pastime - Joe
Last edited by Jackie07; 03-06-2012 at 04:52 AM..
|
Linear Mode
